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The aim of the study was to investigate the myelination effects of low level laser therapy 
(LLLT) following demyelination by topical application of lysophosphatidyl choline 
(LPC) in a rat model (LPC was found to affect myelin and not axonal structures). The 
animals were randomly divided into two groups following topical application of LPC on 
rat’s sciatic nerve. One group was delivered LLLT (40 J transcutaneously) while the 
other group received no laser therapy and served as the control. The nerve tissues were 
harvested on the 7th, 10th, 14th, 18th, 21st and 28th days. The specimens were fixed and 
embedded in araldite. Sections with thickness of 90-150 nm were stained and viewed 
under transmission electron microscope (TEM). The pictures captured were coded, 
measurements of the axonal diameters and the total fiber diameters were made using 
‘Image tool 3.0’ computer software. The axons were classified into 2 groups according to 
their sizes (0-3 µm and 3-6 µm). Myelin thickness and g-ratio (axon:axon + myelin)  
were calculated.  
 
The results were analyzed using the Univariate analysis of variance and Independent t-
test. It was found that the g-ratio and myelin thickness of the laser and non-laser groups 
were comparable after 18th day. On the 7th day in the laser group, it was obvious that the 
g-ratio of the smaller axons was significantly lowered (p=0.000), as well as for the larger 
axonal group (p=0.001). This was due to a significant increase in the myelin thickness for 
both the smaller (p=0.000) and the larger axons (p=0.005). On the 10th day, the laser 
group had similar significant results in the g-ratio as well as a corresponding increase in 
the myelin thickness for both axonal sizes. On the 14th day, the g-ratios were likewise 
 xviii
lowered for both axonal sizes. The myelin thickness was significantly increased for the 
smaller axons in the laser group as compared to the non-laser group however, it was 
comparable for the larger axonal group. On the 18th day, g-ratios were lowered for the 
smaller axons. However, it was not so for the larger axons. On the 21st and the 28th day, 
there were no significant differences between the laser and the non-laser groups for g-
ratio as well as myelin thickness. 
 
LLLT application seemed to significantly increase myelin thickness along with 
significant reduction in their g-ratio as compared to the controls especially following 
the initial phase of demyelination. Therefore, it appeared to play a role in 





Introduction and Literature Review 
1.1 Introduction 
Low level laser therapy (LLLT) refers to the application of low-energy laser to tissues to 
stimulate cellular functions and processes. Currently, LLLT encompasses a range of 
therapeutic implications such as wound healing (Takeda, 1988; Smith et al., 1992; Bisht 
et al., 1994), effective pain reduction (Loh and Keng, 1989; Roynesdal et al., 1993; 
Pinheiro et al., 1998), diagnostics and surgical procedures (Gupta, 1997). Furthermore, 
lasers have also been proven to improve nerve conduction and nerve regeneration 
(Campion et al., 1990; Miloro et al., 2002; Bagis et al., 2003; Shin et al., 2003).  
 
Demyelination of axons, which is one of the causes of neuropathic pain (Devor et al., 
2002), is a common clinical problem. Many demyelinating diseases like trigeminal 
neuralgia, multiple sclerosis, Charcot Marie-Tooth disease and Guillain Barre Syndrome 
manifest with neuropathic pain (Wallace et al., 2003). Demyelination can involve both 
the central and the peripheral nervous systems. Although demyelination has been 
associated with neuropathic pain, the success rate of current treatment strategies remains 
low, which could be due to the lack of complete understanding of its underlying 
mechanisms. Current treatment modalities include peripheral surgeries like neurectomies 
and central procedures like microvascular decompression and radio frequency 
thermocoagulation. However, the adverse effect of these treatments like long lasting 
numbness associated with peripheral surgeries and higher mortality risks associated with 
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central procedures limit their clinical applications. Though medications with 
carbamazepine and other anti-epileptic drugs provide an alternate approach, they are 
associated with untoward side effects in some patients like agranulocytosis, aplastic 
anemia, leukopenia, thrombocytopenia and hepatocellular jaundice complicated with the 
development of tolerance to such drugs (Zakrzewska, 1995). Acupuncture and 
transcutaneous electrical nerve stimulation (TENS) are other alternatives for the 
treatment of such demyelinating diseases but has limited success (Chong and Bajwa, 
2003). Another promising alternative to conventional treatment modalities is LLLT. It 
has also been effective in the treatment of demyelinating diseases like post herpetic 
neuralgia and trigeminal neuralgia (Eckerdal and Bastian, 1996; Pinheiro et al., 1997). 
However, the mechanism of LLLT on the myelination process is obscure and has not 
been well documented. The present study was conducted to investigate the ultrastructural 
changes following LLLT of the demyelinated nerve in an animal model. This study could 
possibly help in explaining the cellular events following LLLT application on  
demyelination. 
 
1.2 Literature Review  
1.2.1 Low Level Laser Therapy (LLLT) 
1.2.1a History of laser therapy in medicine 
Ever since the discovery of ruby laser by Maiman in 1960, the possibility of using lasers 
for treating various conditions have been investigated. By 1963, other lasers like CO2, 
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Argon and Nd:YAG were introduced as surgical tools. Initially, low-level laser was 
believed to have no biological effects and was incorporated in high power units as 
pointers only. In the late 1970’s Mester et al initiated a series of experiments to study if 
LLLT had any carcinogenic potential. But surprisingly, he found an increase in hair 
growth on the shaved area with no carcinogenic effects (Baxter, 1994).   
 
Since the past four decades, lasers are being used commonly in medicine for the 
treatment of various opthalmological disorders and excision or ablation of tumors. 
Analgesic effects of laser bioactivation were used for management of post-herpetic 
neuralgia, backaches and sport injuries. It was also used to increase the acceptance of 
skin drafts and wound healing (Strang et al., 1988; Gupta, 1997). Application of lasers in 
oral and maxillofacial surgery began in mid 1970’s for soft tissue excisions and 
resections of oral cancer (Clayman and Kuo, 1997).  
 
The first semiconductor gallium-arsenide (GaAs) laser was introduced in the market in 
1962 but it was only in the early 1970’s that these low power lasers were commercially 
popular. Since then, various semiconductor diode lasers (pulsed and continuous wave) 
have been produced. Considerable interest was generated in practitioners and researchers 
because of its higher efficiencies and compactness. However, even after thirty-five years 
of the development of these lasers, the exact mechanisms of tissue biostimulation by 
lasers remains elusive (Walsh, 1997). 
 3
1.2.1b Current status of lasers in medicine and dentistry 
Lasers are used commonly in medicine for the treatment of glaucoma, cataract, lens 
defect corrections and diabetic retinopathy. They are used for excision or ablation of 
tumours of cervix, uterus and bladder along with the removal of kidney stones. In 
otorhinolaryngology, they are used in the removal of vocal cord polyps, laryngeal 
stenosis, oral sub mucous fibrosis and to assist in angioplasties (Strang et al., 1988; 
Gupta, 1997). Currently, lasers also find a major place in dental practice. In a review by 
Mercer, (1996 a) different aspects of its usage have been discussed.  Lasers have been 
used in dentistry for increasing the resistance of enamel towards caries, gingivectomy, 
crown lengthening procedures, curettage and scaling. They have also been used for 
curing light- activated composite materials and measurement of facial profiles (Mercer, 
1996 b).  
 
1.2.1c Type of lasers 
Laser is light amplification by stimulated emission of radiation having a monochromatic, 
collimated and coherent beam. The types of lasers used in medicine are- 
Hard lasers / High power lasers 
High power lasers are those, which have an immediate visible effect over the tissues 
when irradiated. The power generated by a high power laser is usually more than 3W 
(Class IV). 
Soft lasers / Low power lasers 
Low power lasers are those, which have no visible effect immediately after application. 
Power generated by low power laser is less than 1000 mW (Class III) (Mercer, 1996 a). 
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1.2.1d Properties of lasers 
1. Coherence:  
Coherent waves are those waves with the same wavelength and have no phase difference 
in time and space among them.   
2. Collimation:  
Collimated light refers to the light waves traveling parallel to each other from a single 
source of origin.  
3. Monochromaticity:     
Light with a single wavelength and color is known as monochromatic. In contrast, normal 
light has various wavelengths in the range of 385-760 nm resulting in white color (Absten 
and Joffe, 1988). 
 
1.2.1e Clinical use of LLLT 
Low-level laser delivers power less than a watt and has an ability to induce athermal 
biological effects upon its interaction with the living tissues. LLLT has been well 
established for reduction of pain (Kreisler et al., 2004), wound healing (Neiburger, 1995) 
and nerve regeneration (Gigo-Benato et al., 2004). 
 
1.2.1f Laser Components 
A laser equipment has the following components:  
1. Pump Source 
2. Active Medium 
3. Laser cavity 
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Pump Source 
The pump source generates electrical or optical discharge. It raises the electrons to higher 
energy levels more quickly than the spontaneous decay, which brings down the electron 
back to the ground state.  
Active Medium                                                                                                                
The active medium in the laser cavity determines the type of the laser. Semiconductors 
used in laser diodes are compounds of gallium arsenide (750 to 900 nm in the infrared), 
indium gallium arsenide phosphide (1200 to 1700 nm in the infrared) or gallium nitride 
(near 400 nm in the blue). In this study, gallium aluminium arsenide (GaAlAs) laser with 
a wavelength of 830 nm was used. 
Laser cavity 
It is made of cleaved crystals along two parallel crystal planes, perpendicular to the 
junction plane. The waves are reflected back and forth between the two parallel surfaces, 
which result in the production of a wave with a higher amplitude than the initial wave 
(Absten and Joffe, 1988).  
  
1.2.1g Working principle of a diode laser 
A semiconductor diode laser has a junction of p-type semiconductor and n-type 
semiconductor, which form the active medium. There are excess electrons in the n-type 
semiconductor and excess holes in the p-type semiconductor. An external electric source 
reduces the gap between the two junctions and allows current in only one direction; and 
acts as open circuit in the reverse direction (Fig.1). As the excess electrons fall to fill the 
holes, photons are emitted giving a light emitting diode (LED). 
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n-type                      p-type n-type                      p-type 
Excess electrons
Excess electrons
Excess holes Excess holes  
 
Fig 1: p-n junction in a diode (Modified from Schawlow, 1963). 
 
For a diode to emit laser, it must fulfill the condition of stimulated emission by 
population inversion. At equilibrium, all atoms have a particular amount of energy and 
after being excited they acquire higher energy levels. The absorbed energy is released as 
a photon, which reaches back to its original ground state. This can be calculated by the 
difference between these two energy levels (spontaneous emission). The excited photons 
upon striking other atoms at higher energy levels would initiate a chain reaction 
producing coherent, monochromatic, electromagnetic radiation. This is known as 
stimulated emission (Clayman and Kuo, 1997). The energy derived for the active 
medium to be excited comes from the pump source.  When most of the atoms reach 
higher energy levels it is known as population inversion, which is necessary for an 























Fig: 2 Basic structure of a diode laser (Modified from Schawlow, 1963) 
 
1.2.1h Laser parameters affecting the outcome of treatment 
 
Wavelength (λ):  
The effects produced by the LLLT are partially dependent on its wavelength (Mendez et 
al., 2004). In the past, shorter wavelengths in the visible range (He-Ne lasers, 632.8 nm) 
were more common. However, with the advent of recent lasers, wavelengths in the near 
infrared region (780-830 nm) are becoming increasingly common (Gigo-Benato et al., 
2005). The wavelength of the laser determines its penetration depending upon the optical 
properties of the tissue. Water, which is the main constituent of all the tissues, absorbs the 
wavelength of above 2 µm. Wavelengths between 600 nm and 2 µm can penetrate deep 




It is the amount of energy delivered per unit area per second and measured in Watts/cm2. 
It is an important factor in determining the laser effect on a tissue.  
                      Power Density     =     Watts x 100    W/cm2
                                                              π r2
Power density is an extremely important factor in determining the effect of LLLT on 
tissue rather than the total dosage. Very low power energies used may not produce any 
biological effect following LLLT application (Tuner and Hode, 1998). In the present 
study, the power density used was 63.7 mW/cm2.
 
 
Fluence / Energy Density: 
It is the amount of energy delivered per unit area and is measured in J/cm2. Higher 
fluence decreases lateral thermal damage (Absten and Joffe, 1988). In the past, energy 
densities as low as 1-6 J/cm2 were used. However, recently higher energy densities are 
being used. Mendez et al (2004) studied the effect of 50 J/cm2 of energy density on 
wound healing. In a study by Gigo-Benato et al (2004), 40 J/cm2 of LLLT was delivered 
for nerve regeneration. Khullar et al (1995) applied 48 J/cm2 in a human trial for sensory 
nerve aberrations. In the present study, the energy density used was 50.95 J/cm2, which 
was comparable to these studies. 
 
1.2.1i Advantages of diode lasers over other laser devices 
1) Ease of operation 
2) Extreme compactness 
3) Higher efficiencies with less power input 
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4) User friendly, cost effective 
5) Non invasive 
 
 
1.2.1j Limitations of diode lasers 
 
1) Limited range of wavelengths available. 
2) Low maximum powers 
3) Optical and electrical damage  
 
1.2.2 Laser- tissue Interaction 
 
The effects of lasers on living tissue are quite complex. The laser parameters like fluence 
(energy), wavelength and pulse duration determine the effectiveness and the interaction 
of laser with living tissues (Mendez et al., 2004).  
 
A laser beam directed towards a tissue can be reflected, transmitted, scattered or absorbed 
(Fig. 3). Reflection and transmission of laser through the tissue produces no effect 
whereas scattering of laser by the tissue surface diffuses the effect over a larger area. 
Absorption of laser energy produces heat effects (Absten and Joffe, 1988; Mercer, 1996 
a). Although with greater angle of incidence, the amount of reflection from the tissues is 
large. Maximum light is delivered when the light is incident and perpendicular to the 
tissues (Prasad, 2003). Absorption of light is characterized by the coefficient of 
absorption (α), which is inversely proportional to its penetration depth (Clayman and 
Kuo, 1997; Gupta, 1997). Hence, the absorption of laser is more for shorter wavelengths 
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and is therefore useful for surgeries where shallow incisions are indicated. Wavelengths 
(λ) in between 600 nm to 2 µm have deeper penetration depths and therefore poorly 







                                                    
Reflection      Transmission





Fig 3: Various effects produced by the application of lasers on tissues. 
(Modified from Absten and Joffe, 1988)  
 
There is a decrease in the energy levels with an increase in the depth of penetration of 
laser. The amount of energy delivered to the nerve is 2-10% of that delivered externally 
to the skin (Rochkind et al., 1989). Nissan et al (1986) also reported similar findings. 
There is a decrease in transmittance of GaAlAs to 13% of the total amount at a depth of  




The interactions between the tissues and laser are very complex and the absorbed energy 
can produce:   
1) Photothermal effect  
2) Photomechanical effect 
3) Photochemical effect 
 
Photothermal effect  
A photothermal effect is the most common effect and is produced in the tissues due to an 
increase in temperature caused by high-energy lasers. With an increase in temperature of 
5-10°C, enzymatic changes, changes in vascular permeability and flow are produced. At 
temperatures of between 45-80°C, denaturation of collagen and denaturation of proteins 
is caused by the breakage of Vander Waal’s forces. Above 100°C, lasers lead to the 
vaporization of tissues (Gupta, 1997) and at temperatures above 150°C, carbonization of 
tissues occur (Prasad, 2003). Photoablation of the tissue is observed at temperatures 
higher than 500°C (Gupta, 1997). 
 
Photomechanical Effect 
A photomechanical effect is produced by high intensity, short pulse lasers resulting in 
very high temperature gradients leading to shock or pressure waves. Such a 
photomechanical effect is used for the removal of tattoos and also removal of kidney 




A photochemical effect is produced because of the excitation of electrons in the 
biomolecules of the tissue. Such an effect can be produced at very low power densities as 
in LLLT. Thus, the molecular and cellular effects produced by LLLT are correlated with 
its photochemical effects.  It is dependent on the fluence rather than the intensity of the 
laser delivered to the tissue (Prasad, 2003).  
 
Absorption of lasers varies with tissue types and is dependent on its optical properties 
(Gupta, 1999). Proteins and DNA, which are the main component of any tissue, absorb 
‘λ’ in between 200-300 nm. NADH absorbs at 270-350 nm in the visible range. Water is 
the major constituent of any tissue and it does not absorb energy till the near infrared 
range. It absorbs energy for wavelengths in between 1.3–10 µm. Hence, the tissues and 
cells are spared of any thermal effect near the infrared range. Prasad (2003) proposed that 
the optical penetration depth is largest for ‘λ’ in between 800-1300 nm. 
 
 
1.2.2a Proposed cellular mechanisms for laser biostimulation 
 
A significant increase in cell growth and proliferation, with increase in DNA synthesis 
and motility has been reported following LLLT application. It also increases 
phagocytosis and proliferation of lymphocytes (Walsh, 1997). Increased collagen 
synthesis has also been reported following LLLT application (Strang et al., 1988). 
Irradiation with red light regulates the expression of genes in human fibroblasts. 
Expression of several genes related to antioxidation and mitochondria can be observed 
following irradiation (Zhang et al., 2003). An increase in macrophages and degranulation 
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of mast cells has also been reported following LLLT (El Sayed and Dyson, 1994; 
Rajaratnam et al., 1994). Proliferation of Schwann cells following laser irradiation has 
also been reported (Van-Breugel and Bar, 1993). 
 
1.2.2b Proposed molecular mechanisms for laser biostimulation  
Biostimulation of lasers results from the activation of respiratory enzymes and 
antioxidation effect. The process is dependent upon the amount of ADP (adenosine di 
phosphate), which is in turn dependent on the utilization of ATP (adenosine tri 
phosphate) by the tissues leading to an increase in the rate of aerobic phosphorylation. 
Hence, the amount of ATPs and ADPs increase after the use of therapeutic lasers.  As a 
result of the increased energy, mitochondrial DNA replication and Gо-S phase of the cell 
cycle is accelerated (Karu, 1989). It may even lead to the production of free radicals, 
which are used in photodynamic therapy (PDT) for cancer treatment (Gupta, 1997). It is 
believed that the effect of laser biostimulation may be associated with humoral factors 
too, as the effect of laser irradiation is not localized to the exposure site (Navratil and 
Kymplova, 2002). Systemic effect of lasers in the peripheral nervous system (PNS) and 
the central nervous system (CNS) was also reported by Rochkind et al (1989). Irradiation 
of wounds is also associated with a significant increase in collagen fibres (Alam et al., 
2003). An increase in the prostaglandin content was also observed following irradiation 
with 1 J/cm2 of energy (Clayman and Kuo, 1997). Many other authors have reported an 
increase in the RNA synthesis, cell motility (Haas et al, 1990), cell granule release 
(Basford, 1989) and neurotransmitter release (Basford, 1989; Basford, 1993). 
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1.2.2c LLLT and nerve studies 
LLLT and transected nerves  
The first successful nerve regeneration of the transected rat sciatic nerve after epineurial 
repair using CO2   laser was reported in 1982 (Dew et al., 1982). They reported good laser 
assisted epineurial repair compared to controls. Moreover, the laser-assisted repair was 
observed to produce minimal neural damage and better alignment as compared to the 
conventional microsurgical procedure. 
 
Campion et al (1990) reported that laser-assisted nerve repair was superior compared to 
the suture-assisted repair. The authors studied the effect of argon laser to repair transected 
peroneal nerve of rabbits (power density 100 W/cm2, pulse duration 200 ms, spot size 0.5 
mm via microscope with micromanipulator). It was reported that there was no significant 
difference in the functional recovery between the suture repaired nerve and the laser 
assisted groups after 1 month post-operatively. Neither was any difference observed in 
their axonal diameters. Two months post-operatively, a significant increase in the axonal 
diameters in the laser-assisted group was reported compared to the suture-assisted group. 
Similar findings were observed following 6 months post-operatively. However, the 
axonal diameters were not comparable to the baseline controls wherein no surgery was 
conducted. 
 
Miloro et al (2002) determined the effects of LLLT on neural regeneration in Gore Tex 
tubes. 10 post-operative treatments with a 70 mW GaAlAs diode with continuous 820-
830 nm laser beam with energy density of 6 J/cm2 for 90 seconds per treatment was used. 
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They noticed a significantly higher average axonal diameter and axonal density for the 
laser treated group compared to the control group. It was hypothesized that the positive 
effect of lasers on neural regeneration might be due to the release of neurotrophic factors 
or light sensitive, rhodopsin kinase-type enzyme protein. Similar explanation was also 
given by Khullar et al (1996). 
 
In another study by Gigo-Benato et al (2004), the effect of laser biostimulation after end 
to side neurorrhaphy in the rat median nerve was observed. One group of animals in this 
study was treated with InGa(Al) lasers with continuous wavelength  of 808 nm, fluence 
of 29 J/cm2 for 39 seconds over a spot size of 0.28 cm2. In another group, InGa(Al) laser 
with pulsed wavelength 905 nm,  with spot size of 0.1 cm2 and fluence of 40 J/cm2 was 
used. A third group included combination therapy for thrice a week for 3 weeks. Faster 
healing was observed compared to the control non-laser group. 16 weeks post-
operatively, control group had a total of 10% of the normal fibre density whereas, the 
laser treated group had a total of 65% of the normal fibre density. However, it was 
highest for the combination laser therapy being 85% of normal. Mean fibre diameter was 
18% of normal in the non-laser group as compared to 34% for pulsed 904 nm laser, 37% 
for continuous 808 nm and 45% for the combination group. 
 
In 1989, Benke et al used laser therapy along with conventional suture repair to study its 
effect. It was found that the average diameters for the proximal portion of the nerve were 
higher in laser-assisted repaired nerve than compared to the suture repaired nerve only. 
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Laser-assisted repaired nerves were found to have lower stimulation threshold (Benke et 
al., 1989). 
 
The effect of LLLT on the release of neurotransmitter at the neuromuscular junctions of 
mouse was studied by Nicolau et al (2004). In their study, energy densities of 4 J/cm2 and 
12 J/cm2 were used. The authors reported that LLLT with an energy density of 12 J/cm2 
affected neurotransmitter release with a reduction in the acetylcholine (ACh) release. In 
another study by Anders et al (2004), increase in ACh has also been reported following 
laser irradiation with He-Ne laser. An increase in ACh level with the use of ruby laser has 
been reported elsewhere by Basford (1989).  
 
LLLT and crush injuries of nerves                                                                               
Shin et al (2003) verified the therapeutic effects of LLLT on neuronal regeneration by 
finding elevated immunoreactivities of growth-associated protein-43 (GAP-43), which 
increases with neural regeneration, and sprouting. Five cycles of 650 nm, 5 mW 
continuous laser beam of 5 mm diameter for 5 minutes were repeated immediately after 
injury for 4 consecutive days. For the first time it was proposed that LLLT has an effect 
on the initial stages of nerve regeneration following crush injuries. 
 
In another study, bilateral crush injuries were caused on the rat’s sciatic nerves. GaAlAs 
laser with wavelength of 904 nm, and three different energy densities of 0.31, 2.48 and 
19 J/cm2 were used. No morphological and electrophysiological differences were noted in 
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the control and the test group (Bagis et al., 2003). The probable explanation for such a 
result may be due to the systemic effects of LLLTas reported by Rochkind et al (1989).  
 
In a study by Khullar et al (1995), no histological improvement was observed following 
compression injury of rat’s sciatic nerve and laser therapy with (GaAlAs 820 nm), with a 
fluence of 48 J/cm2. The energy delivered was 6 J on daily basis for 28 days. However, 
significant reduction in the sciatic nerve index was observed which explained the 
improvement in functional recovery.  
 
LLLT and human nerve studies 
In another study by Khullar et al (1996) on human subjects, the effect of GaAlAs 820 
nm, 48 J/cm2 over a spot size of 0.13 cm2 for sensory aberrations in the inferior alveolar 
nerve was observed. Patients received 4 x 6 J of energy for 20 treatments. An overall 
improvement in mechanoreceptor sensation was observed. The authors proposed the 
possibility of collateral reinnervation with the release of neurotrophic factors within the 
affected area or the release of light-sensitive, rhodopsin kinase present in different parts 
of the nervous system. 
 
LLLT and normal nerve  
Comelekoglu et al (2002) studied the acute electrophysiological effect on normal sciatic 
nerve in frogs. The author used laser energy levels varying from 0.0015 J to 0.684 J 
delivering energy densities between 0.005-2.5 J/cm2 of GaAlAs laser with λ of 904 nm. 
Pulse repetition rates of 4, 8, 16, 32, 64 and 128 Hz were used. No significant difference 
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between the action potentials and conduction velocities was observed. In contrast, 
Snyder-Mackler and Bork (1988) found a significant decrease in nerve conductivity with 
increased latencies following the use of He-Ne laser over a period of 20 seconds in 
normal human superficial radial nerve, which might be a possible explanation of its 
analgesic effect. In another study, Rochkind et al (1989) determined the effect of LLLT 
on a bare nerve. The authors found that LLLT merely increased the temperature of the 
tissue by 0.1 ºC. Since this temperature is much lower than needed to produce any 
cellular effect, the notion that laser therapy caused this effect due to temperature change 
was ruled out. It was proposed that LLLT produced some systemic effects by reducing 
the retrograde degeneration produced by crush injuries in the sciatic nerves in the spinal 
cord among the laser treated group as compared to the control. It was also discovered that 
the energy delivered to the nerve was 2-10% of the total energy delivered to the skin. 
Reduction in the transmission of laser energy with depth was also reported elsewhere 
(Kolari and Airaksinen, 1988).  Rochkind et al (1986) found an increase in the action 
potential (AP) of a normal nerve following irradiation. The authors even reported that in 
bilaterally cut sciatic nerves in rats, AP on the irradiated side decreased more slowly 
compared to the control side. Similar findings were even reported by Rochkind et al 
(1988).   
 
Assessment of these studies is difficult because of the use of different lasers with varying 
parameters used. Studies have suggested that there are beneficial effects of LLLT on 
nerve regeneration (Miloro et al., 2002; Gigo-Benato et al., 2004) and its recovery 
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following injuries (Shin et al., 2003). Improved mechanoreceptor sensations have also 
been reported in clinical investigations (Khullar et al., 1996).  
 
1.2.2d LLLT and pain 
LLLT has been found to be beneficial in reduction of post-operative pain. Walker (1983) 
reported the first controlled study showing the analgesic effect of LLLT. In a study by 
Mezawa et al (1988), it was found that the firing threshold frequencies were decreased 
following LLLT application. Lim et al (1995) have also described the analgesic effect of 
LLLT following orthodontic post-adjustment pain. Pinheiro et al (1997) reported 
considerable improvement of pain in conditions like temporomandibular joint (TMJ) 
disorders, trigeminal neuralgia, muscular pain and tooth sensitivity. It was suggested that 
LLLT might increase the release of β-endorphins leading to pain reduction.  In a recent 
report, the efficacy of LLLT was tested following endodontic surgery. Pain reduction was 
observed 7 days post-operatively (Kreisler et al., 2004). However, Roynesdal et al (1993) 
and Fernanado et al (1993) reported no effect on pain reduction following third molar 
surgeries. 
 
1.2.2e LLLT and wound healing 
LLLT’s effect on wound healing is well established (Strang et al., 1988; Neiburger, 
1995). It is believed to enhance procollagen type I and type III, mRNA production along 
with their cross-linking and improving the quality of regenerating collagen (Strang et al., 
1988). Mendez et al (2004) also reported increased collagen following laser therapies 
using (GaAlAs, 830 nm, 50 J/cm2), (GaAlAs, 830 nm + InGaAlP, 635 nm, 50 J/cm2) and 
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(GaAlAs, 830 nm + InGaAlP, 635 nm, 20 J/cm2) following cutaneous wounds in rats. It 
is also believed to intensify vascularization in the regenerating tissues and to have an 
immunosuppressive effect, which helps to accelerate wound healing (Strang et al., 1988). 
LLLT stimulates the production and maturation of fibroblasts. Increase in the cell 
proliferation and basic fibroblast growth factor (bFGF) has also been reported (Wei Yu et 
al., 1994). LLLT has been shown to increase the motility of the keratinocytes and hence 
accelerating the healing process (Haas et al., 1990). LLLT is also supposed to increase 
the phagocytic and chemotactic activity within the first 6 hours following trauma 
(Rajaratnam et al., 1994). Although, laser application has shown to accelerate the 
formation of bone matrix and production of fibroblasts, the effect of LLLT on bone 
regeneration is controversial (Takeda, 1988). LLLT also inhibits bacterial growth and 
hence creates an aseptic environment (Mercer, 1996 a). 
 
 
1.2.2f LLLT and anti-inflammatory effects  
 
LLLT has been shown to abate the production of postoperative inflammatory mediators 
of the arachadonic acid family from injured nerves and to enhance neuron maturation and 
regeneration following injury (Walsh, 1997). It also reduced postoperative pain by 
interfering with the mediation of pain message or stimulation of the endorphins (Khullar 
et al., 1996).  In a study by Freitas et al (2001) plasma levels of C-reactive protein (CRP) 
were measured in twelve patients following laser therapy with 830 nm diode laser (40 
mW, 4.8 J/cm2). Although, no significant differences were observed between the 
irradiated and the non-irradiated groups, the distribution of CRPs was more symmetric 
for the laser group.  
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1.2.2g Contraindications of laser therapy  
Laser therapy is contraindicated in malignant carcinomas because of the positive effect 
on mitochondrial DNA and cell growth. They are also believed to stimulate seizures in 
epilepsy and hence are not used for such patients. Irradiation of retina is not indicated as 
it might lead to blindness. Although therapeutic lasers have not been proved to be 
teratogenic, direct irradiation of abdominal and intravaginal region is not advised in 
pregnant women. Lasers are contraindicated in massive blood loss too as they have a 
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Fig 4: Cross-section of a peripheral nerve fibre with three fascicles 
(Modified from Schaumburg et al., 1992) 
 
A nerve is a basic component of the nervous system, which transmits impulses from the 
CNS to the periphery and vice-versa. It consists of an outer layer called the epineurium, 
which contains numerous nerve bundles covered by a layer called perineurium. Inside the 
perinueurium are numerous small nerve bundles, which are clustered together in a layer 
of endoneurium (Fig.4). All the nerve fibres that are covered by an insulating sheath 
(myelin) are called myelinated fibres whereas, those that are not covered by this sheath 
are known as unmyelinated fibres (Schaumburg et al., 1992). The structure of myelinated 
fibre is difficult to distinguish under light microscopy. Special staining like luxol fast 
blue and erichrome cyanin are particularly used to stain myelin. However, the myelin 
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lamellae and the changes in it are clearly observed under electron microscope (Schroder, 
2001). The ultrastructure of myelinated nerve fibre showing myelin sheath, basal lamina, 













Fig 5. Myelinated nerve fibre (Ultra-structure). Transversely sectioned axon (A) with the 
outer compartment of the Schwann cell cytoplasm (C), basal lamina (Bl) and Schwann 
cell nucleus (N), Myelin (M) of rat’s sciatic nerve  
 
In a myelinated nerve fibre, myelin sheath is not continuous throughout the axon but is 
periodic. The places devoid of myelin sheath are known as nodes of Ranvier. The area 
covered by myelin sheath between two nodes of Ranvier is called as an Internode. 
Adjacent the node is paranode where, the myelin sheath is furrowed and is in the form of 
microvilli. Paranodal regions contain large number of mitochondrias and paranodal 
axoglial junctions stabilized the myelin sheath. It was also believed that any pathology in 
the paranode could expose the internode to the extracellular space and disrupt its 
function. Myelin sheath is a compact structure formed outside the axons but it might lose 
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its compactness at some areas and they are known as Schmidt Lanterman incisures 
(Waxman, 1985). 
 
1.2.4 Myelin  
 
1.2.4a Historical perspectives  
In 1872, Ranvier related an internode surrounded by a Schwann cell to a fat droplet in an 
adipocyte. It was believed that myelin sheath was derived from an axon and not the 
Schwann cell. It was believed that myelin was a continuous structure with no 
interruption. In 1925, Lillie’s work proposed the existence of discontinuous conduction 
(saltatory conduction) through the myelin sheath. It was only in 1940’s that the structure 
of myelin sheath was described. With the introduction of electron microscope, the 
relationship between the axon, Schwann cells and myelin became explicit (Hildebrand et 
al., 1994).  
 
1.2.4b Current opinion  
Myelin sheath is a membrane characteristic of the nervous tissue, laid down in segments 
along the axons of selected nerve fibres and wrapped spirally along the axons (Morell, 
1984). It is an insulating material, which functions to increase the velocity of nerve 
impulses along the nerve fibre (Waxman, 1985). It has a higher lipid to protein ratio (7-8: 
2-3) in the myelin sheath, which makes it electrically insulating for saltatory conduction. 
Myelin does not consist of any special lipids. However the contents of 
monogalactosylsphingolipids, cerebrosides (Gal-C) and sulfatides (SGal-C) are much 
higher. The special protein content and higher proportions of very long-chain fatty acids 
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also contribute to its special insulating properties. These include glycoproteins (60%), 
basic proteins (20-30%) and other diverse proteins. Among all the lipids in the myelin 
sheath, cholesterol contributes to 20-30% in the PNS. It has also been reported that the 
lipid content of myelin sheath increases with age (Garbay et al., 2000). 
 
1.2.4c Development of myelin in a peripheral nerve  
 
Development of myelin in a peripheral nerve begins with a naked axon of around 0.7 µm. 
Schwann cells from the neural crest migrate along the axon, proliferate and acquire one 
to one relationship with the axons. Following which, they secrete the basal lamina and 
initiates myelination (Garbay et al., 2000). Many cell adhesion molecules (CAMs) like L1 
adhesion molecule are down regulated with myelination whereas, myelin–associated 
glycoprotein (MAG), a glial CAM which promotes association with internodal axolemma 
is upregulated after the initial stages of myelination. Thus, all CAMs and ionic channels, 
which are evenly distributed before myelination, redistribute to form distinct domains 
that are critical for propagation of AP and impulse conduction (Salzer, 2003). Axonal 
contact of Schwann cells is required for the expression of the myelin genes during 
development. These myelin genes are down regulated following nerve injury. The axonal 
signals that initiate and regulate myelination process are still largely unknown (Garbay et 
al., 2000). However in a recent study, Michailov et al (2004) discovered that growth 





1.2.4d Cross sectional growth of myelin 
It was proposed by many authors that the myelin sheath grows radially in a linear relation 
to its axonal diameter, whereas other authors proposed a non-linear relationship 
(Hildebrand et al., 1994). It was later observed that the linear growth of myelin exists for 

















Fig. 6   Schematic diagram showing the measure of g-ratio, which is the measure of 
axonal diameter to the total fibre diameter, determined by A:B as shown 
 
‘g- ratio’ is a well established parameter used for determining the myelin thickness. It is 
given by dividing axonal diameter by the total diameter of nerve fibre (axon diameter: 
axon diameter + myelin thickness) (Hildebrand et al., 1994; Constant et al., 2004). It has 
also been reported that conduction velocity in a nerve fibre is indirectly dependent upon 
the g-ratio (Hildebrand et al, 1994). For optimal nerve conductivity, the g-ratio of the 
axons must lie between 0.6 and 0.7 (Smith and Koles, 1970; Waxman, 1985; Hildebrand 
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et al., 1994). The g-ratio reaches the range of 0.6-0.7 at the time of birth and remains the 
same thereafter for almost 90% of the axons implying that Schwann cells continue to 
maintain the myelin thickness proportional to the axonal growth. Lower g-ratio values of 
0.5 or less have also been observed for smaller myelinated axons that have been related to 
artefacts in light microscopy. It is even proposed that g-ratio may exhibit a different 
range for thick and thin myelinated fibres (Hildebrand et al., 1994). The g-ratio is 
observed to increase in demyelination or thinly myelinated axons (Wallace et al., 2003) 
and decrease in value in hypermyeliantion (Ansselin et al., 1998).  
 
There are various other parameters, which can also be used for determining the myelin 
thickness in a nerve. It can be determined by measuring the diameter of the fibre 
(maximum, minimum and mean), perimeter of the nerve fibre and cross-sectional area of 
the nerve fibre. 
 
1.2.4f Regulation of myelin thickness  
It was earlier believed that glial cells (Schwann cells in PNS and oligodendrocytes in 
CNS) were responsible for the maintenance of g-ratio or the number of myelin lamellae 
around the axons. However, recently it was discovered that myelin thickness was actually 
dependent on the axonal diameter (Gautron et al., 1990; Constant et al., 2004; Michailov 
et al., 2004). A growth factor neuregulin (Ngr 1 type III) was found to be responsible for 
regulating myelin thickness but it was not found to be associated with the internodal 
length (Michailov et al., 2004). Laminin deposition over the surface of the Schwann cells 
is also essential for myelination (Podratz et al., 2001). 
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1.2.4g Longitudinal growth of the myelin 
It was established that larger axons myelinated earlier than the smaller axons with longer 
internodal distances. It was also believed that the internodal length was dependent of the 
Schwann cell length and post-myelination growth. Variations exist between nerve to 
nerve and between fibres of the same nerve (Hildebrand et al., 1994; Michailov et al., 
2004).  
 
Growth of the myelinated fibre leads to the domain formation of the nodal and the 
paranodal region. Ionic channels and CAMs are well distributed all along the axonal 
fibres. As myelination progresses, all such molecules and channels get concentrated in 
specialized domains. These domains are responsible for the generation of action potential 
in the myelinated fibres (Salzer, 2003). Saltatory conduction of the impulse propagation 
is due to the high concentration of voltage-gated sodium channels (Nav) at the nodes of 
Ranvier along with the low capacitance and high resistance of myelin sheath (Waxman, 
1985). Unmyelinated fibres have a constant flow of impulses with diffuse distribution of 
ionic channels. 
 
Pulsating electromagnetic field (PEMF) and increased cAMP was shown to accelerate 
axonal growth. cAMP is also indirectly related to myelination. Nerve growth factor 
(NGF) has also been found to promote axonal growth. It is also believed that Schwann 
cells in a degenerating axon produce acidic 37 kDa protein, which may play a role to 
attract axons. Hormones like adrenocorticotrophic hormone (ACTH) and L-
thyroxinsodium (T4) are also found to influence axonal growth (Lundborg, 1987). 
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1.2.4h Role of sodium channels 
In a normal nerve, voltage gated sodium (Na) channels are clustered at the nodes of 
Ranvier (Salzer, 2003; Constant et al., 2004). The number of channels in the internodal 
region is sparse and not enough for disruption of impulses (Waxman, 1985; England et 
al., 1991). Since the internodal Na channels are covered by an insulating myelin sheath, 
they do not play a role in the saltatory conduction in a myelinated fibre. England et al 
(1991) proposed that there was an increase in the number of Na channels after 
demyelination and not a mere redistribution of the channels in the internodal region. The 
authors made use of Ferric ion-ferrocyanide staining and radioimmunoassay to 
demonstrate reorganization and an increase in the number of Na channels at 14 to 21 
days.   
 
Meiri et al (1986) injected LPC in the rat’s sciatic nerves and found that demyelinated 
axons had lower density of Na channels. Some axons had modified distribution of Na 
channels whereas; they were absent in axons with acute demyelination. 
 
1.2.4i Age changes in myelin sheath  
Myelin sheath shows remodeling and structural changes with age. Peters et al (2003) 
reported accumulation of dense cytoplasm containing lysosomes, vesicles and amorphous 
dense bodies in splits between lamellae of the sheaths, formation of fluid filled balloons 
in splits. Presence of redundant myelin (double myelin) was also reported in a study done 
on monkeys (Peters et al., 2002), rats and guinea pigs (Hildebrand et al., 1994). This 
feature has been observed in many autonomic nerves and superior cervical ganglia of the 
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rat and guinea pigs. In a single cross-section of a nerve, 4% of the axons depict double 
myelination. It is even reported that the outer layer in a doubly myelinated axons is not 
lost following experimental denervation (Hildebrand et al., 1994). Some other authors 
reported no changes between the nerves of old and young monkeys. Presence of thicker 
fibrous trabeculae and hypertrophied astrocytes were also reported (Sandell et al., 2001). 
 
1.2.4j Differences between PNS and CNS myelin sheaths 
PNS and CNS myelin differ from each other biochemically, in their origin and structure 
but they function identically. Schwann cells are the cells that give rise to myelin sheath in 
the PNS whereas; Oligodendrocytes are the cells of myelin origin in the CNS. In the 
PNS, the nodes of Ranvier are contacted by hundreds of microvilli that project from the 
ends of Schwann cells whereas the peri-nodal processes of specialized glia in the CNS 
project to many but not all nodes (Waxman, 1985). Basal lamina covers the myelin 
sheath and is continuous along the nodes of Ranvier in the PNS however; CNS myelin is 
devoid of basal lamina (Waxman, 1985; Salzer, 2003). It was believed that Schwann cells 
produced basal lamina, which accelerated the regeneration of peripheral nerve fibres 
(Waxman, 1985). Differences exist in the lipid content of the PNS and the CNS too. 
Sphingomyelin accounts for 10-35% of the total myelin content in the PNS as compared 
to 3-8% in the brain tissue. Ethanolamine phosphoglycerides are much more in the PNS 
compared to those with choline, and plasmalogens (phosphatidalcholine and 
phosphatidalethanolamine). Differences are also observed in the ganglioside contents 
(Garbay et al., 2000). 
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1.2.4k Schwann cells 
Schwann cell proliferation is observed during development of myelin sheath but adult 
cells rarely divide. However, under pathological conditions, following axotomy and 
under the influence of chemicals in experiments, mitosis of Schwann cells is quite 
common. Schwann cell proliferation was observed following topical application of 100-
300 µl of 2% lysolecithin-induced demyelination following 4th day (Griffin et al., 1990). 
Schwann cells can also transform to phagocytes following nerve injuries and engulf the 
axons and myelin remnants (Pannese, 1994). 
 
1.2.4l Changes observed following nerve injury 
 
Following a nerve injury in the first few days, the proximal segment of the nerve shows 
characteristic changes with collateral sprouting and the distal most part of each sprout 
shows the presence of ‘growth cone’, which is described as a swelling with several 
microspikes. Distal segment of the nerve shows changes as in Wallerian degeneration 
with phagocytosis of myelin sheath by Schwann cells and macrophages (Lundborg, 
1987). Proliferated Schwann cells line up in columns and are termed as ‘Bands of 
Bungner’ (Albert, 1979). Increased collagen content is also observed (Lundborg, 1987). 
 
1.2.4m Conduction speed of nerve impulses 
Conduction of nerve impulses in a nerve fibre is proportional to the fibre thickness 
(Waxman, 1985). In a non-myelinated fibre, the conduction velocity is said to be 
proportional to the square root of the diameter of nerve fibre whereas, a linear 
relationship is established in a myelinated fibre (Rushton, 1951). Conduction in a 
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myelinated fibre is hence faster compared to a non-myelinated fibre of the same diameter. 
Saltatory conduction or discontinuous conduction through the nodes of Ranvier was first 
proposed on the basis of Lillie’s work in 1925 however; it was demonstrated 
experimentally only in 1940’s (Hildebrand et al., 1994). Myelinated fibres have shorter 
refractory periods compared to non-myelinated fibres and the transmission frequencies 
are higher compared to the non-myelinated fibres. 
 
Conduction in a myelinated fibre may not be discretely discontinuous. It has been 
proposed that the action potential may spread up to ten nodes of Ranvier at a time. 
Conduction of impulses in non-myelinated fibres is not always continuous either. It was 
suggested that some differentiation of the axonal membrane occurred before complete 
myelination leading to the clustering of Nav channels at the nodal regions (England et al., 
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Fig 7: Figures showing myelinated and demyelinated nerve axons 
 
 
Demyelination is characterized by splitting or swelling of the myelin lamellae and may 
lead to its complete destruction without any effect on the axons. Demyelination may 
result from mechanical, pathological or chemical means.  
 
1.2.5a Chemical agents in demyelination 
Various animal models for chemical demyelination have been developed in the past using 
diphtheria toxin, ethidium bromide, cuprizone, hexachlorophene as well as lysolecithin in 
both the PNS and the CNS (Hall and Gregson, 1971; Rosenbluth, 1995). Doxorubicin has 
also been used for chemical demyelination (England et al., 1991). Central demyelinating 
model like experimental allergic encephalomyelitis (EAE) has also been developed. 
Knock out mice with disturbances in gene for myelin basic protein (MBP) has also been 




1.2.5b Lysolecithin / Lysophosphatidyl choline 
Demyelination is associated with an increased LPC and phospholipase A activity. LPC 
has a high affinity for certain myelin proteins and can modify membrane activity along 
with rehydration of the intraperiod lines. LPC is an enzyme present in the normal 
peripheral nerves and its reacylation and hydrolysis are important in maintaining its level 
in a peripheral nerve (Low et al., 1983).  
 
Some authors believed that demyelination due to LPC was due to its detergent action 
leading to lysis of myelin sheath and formation of complexes with lipids and proteolipids 
in an aqueous medium (Mitchell and Caren, 1982; Triarhou and Herndon, 1985; Love et 
al., 1986). While some authors believed it to be due to more specific interactions induced 
by lysophospholipids, others believed that demyelination caused by LPC was not due to 
its catabolic products but by LPC as a whole (Low et al., 1983). 
 
LPC has been widely used as a demyelinating agent in many studies. The animal model 
for peripheral demyelination was developed first by Hall and Gregson (1971). The 
authors injected phospholipase A and LPC subperineurally. Splitting of the myelin 
lamellae and widening of Schmidt Lanterman incisures within the initial 30 minutes was 
observed. After 48 hours, remnants of myelin sheath were left and on the 6th day, myelin 
debris was removed whereas, on the 14th day remyelination was well established. The 
authors made use of four different concentrations of LPC (2, 5, 20, 25 mg/ml). By the 
40th day, all the remyelinated fibres formed in various animals treated with high 
concentration of LPC and lower concentrations looked alike. It was concluded that LPC 
was a demyelinating agent, which did not have any effect on axons and Schwann cells. It 
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was hypothesized that neural tissues had the ability to acylate LPC and convert it into 
phosphatidyl choline (Hall and Gregson, 1971). Whereas, Mitchell and Caren (1982) 
found lysis of Schwann cells and degeneration of non-myelinated fibres 24 hours after 
intraneural injection of 2-3 µl of 10 mg/ml of lysolecithin. It was believed that the lytic 
action of lysolecithin was responsible for the disappearance of Schwann cells containing 
myelin debris at the end of 48 hours. It was also proposed that the myelin sheath 
surrounding the fibres absorb all the lysolecithin and undergo degeneration leaving the 
axon fibres unaffected. But, in unmyelinated fibres the lack of protective covering of 
myelin sheath led to their degeneration by direct exposure to the chemical agent. 
 
In another study by Griffin et al (1990), Schwann cell proliferation was observed after 
topical application of lysolecithin on sciatic nerve of rats on the 4th day. Schwann cell 
proliferation is an extremely slow process under normal circumstances in adult nerve. 
However, the rate of proliferation might increase in disease process with the loss of 
myelin sheath. The study showed that the effect of lysolecithin was clearly visible at the 
end of 4th day. Three different zones in a myelinated axon were observed. The immediate 
subperineurial zone showed complete demyelination and supernumerary Schwann cells. 
By day 6, increasing number of remyelinating fibres were identifiable. Below this zone 
was a zone with lipid droplets, myelin vesiculation and supernumerary Schwann cells and 
the normal innermost zone (Griffin et al., 1990). 
 
Hall (1984) did multiple injections of LPC into the rat’s sciatic nerve and found that with 
a single injection of LPC, maximum vesicular breakdown occurred on the 4th day and 
remyelination started on the 8th day. 90% of the fibres were remyelinated by the 10th day 
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following injection of LPC. For those animals which were injected 4 times, little 
remyelination was observed on the 9th day postoperatively whereas, it was absent in 
animals with 8 injections (Hall, 1984). 
 
Jennings et al (1989) demonstrated the presence of periaxonal tubular structures after 
injecting 2.5-3 µl of 1 % LPC in the first few hours. The tubules increased in number 
with the dissolution of external myelin lamellae but were absent at the end of 48 hours 
following injection. It was believed that the tubules would have originated from myelin 
lamellae or Schwann cell membrane (Jennings et al., 1989) however, Hall (1971) did not 
report such changes. 
 
In another study, it was demonstrated that active participation of macrophages was 
required for demyelination apart from clearing the myelin debris. The group, which was 
pretreated by silica quartz showed less phagocytic activity (Triarhou and Herndon, 1985). 
Kotter et al (2001; 2005) also reported similar findings in the CNS demyelinating 
models. It was also reported that an increased number of macrophages in the initial stages 
of demyelination, enhanced remyelination (Kotter et al., 2001). It was later explained by 
Kotter et al (2005) that response of macrophages to toxin-induced demyelination might 
influence the growth factor environment and hence remyelination. 
 
1.2.5c Conduction in a demyelinated nerve fibre 
Conduction in a demyelinated nerve can be blocked, slowed or continuous due to altered 
myelin (Foster et al., 1980). Computer generated model for conduction in a demyelinated 
axon by Koles and Rasminsky (1972) indicated that even a presence of 2.7% thickness of 
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the original myelin thickness could dramatically improve the conduction of impulses in a 
remyelinated fibre (Koles and Rasminsky, 1972).  
 
From the literature review, it has been found that even after 35 years following the 
introduction of LLLT, the exact mechanisms of biological responses of LLLT are not 
clearly understood. Animal experiments and clinical trials have provided us with critical 
information of its effects on wound healing, pain and nerve regeneration. LLLT has been 
found to be a potent stimulator for nerve regeneration following axotomies and crush 
injuries (Khullar et al., 1996; Shin et al., 2003). Studies have shown that topical 
application of LPC leads to the demyelination of axons without axonal degeneration 
leading to a pure demyelination model. To the best of the author’s knowledge, there was 
no reported study on the effect of LLLT on focally demyelinated nerve using lysolecithin. 
The results of the present study might provide an understanding of the mechanism of 




To determine the myelination effects of LLLT on the rat’s sciatic nerve following 
lysolecithin-induced focal demyelination with particular emphasis on 
 
(i) the rate of remyelination and myelin thickness as compared with the controls. 
 




Based on the knowledge gained from the literature review, it could be hypothesized that 
LLLT may have some myelination effects.  
 
1.4.1 The Null Hypotheses are: 
1.4.1a There is no significant difference between the g-ratio of axons with LPC induced 
focal demyelination following LLLT and those without LLLT. 
 
1.4.1b There is no significant difference between the myelin thicknesses of axons with 
LPC induced focal demyelination following LLLT and those without LLLT. 
 
1.4.2 Alternate Hypotheses are: 
1.4.2a There is a significant difference between the g-ratio of axons with LPC induced 
focal demyelination following LLLT and those without LLLT. 
 
1.4.2b There is a significant difference between the myelin thickness of axons with LPC 




Materials and Methods 
2.1 Animal Model 
This in vivo study was conducted on ‘Wistar’ male rats, as they are easily bred and 
economical.  Moreover, rats have been used in many of the studies to determine the 
effects of LLLT on nerve regeneration (Campion et al., 1990; Miloro et al., 2002; Bagis 
et al.; 2003; Shin et al., 2003). Sciatic nerves from mice would have been much smaller 
and difficult to handle. Larger animals like rabbits would have been appropriate for 
harvesting nerve tissue. However, the cost of procuring and maintaining such a large 
number of rabbits was prohibitive. Hence, mice and rabbits were not used in this 
experiment. The aim of this study was to study the myelination effects of LLLT on focal 
induced demyelination by lysolecithin in rat’s sciatic nerve. 
 
2.2 Pilot Study 
A pilot study was designed to determine whether the chosen laser parameters were 
suitable. In our pilot study there were 4 groups of animals, 1 saline group, 1 lysolecithin 
group and 2 laser groups with energy levels of 40 Joules and 80 Joules respectively. The 
laser parameters chosen were dependent on those commonly used in dentistry and for 
nerve regeneration (40 J). A higher energy level of 80 J was also used to observe its 
effect on demyelinated nerve. At the end of the pilot study it was found that 80 J of laser 
energy had a negative effect on the nerve fibres. It led to axonal atrophy at the end of 21 
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days following demyelination and laser therapy (Fig.36, Appendix 4). Hence, this group 
was discarded from the main experiment. A comparison was made with a saline group in 
order to rule out the effect of saline on nerve fibres. An additional group on the 4th day 
was also added to observe the effect of 10 µl of 15 mg/ml of LPC on that day (Fig. 32, 
34, 35, Appendix 4). 
 
Double the concentration of topical LPC (30 mg/ml) against the normal (15 mg/ml) 
dosage was also tested in a rat. However, the animal could not survive after 3rd day 
postoperatively, so this concentration of LPC was not used for the main experiment. 
 
2.3 Experimental Setup 
The project was approved by the Institutional Research Board and ethic’s committee of 
NUS. International guidelines for animal research were adhered to (Howard-Jones, 
1985). 
 
2.3.1 Study design  
 
60 adult Wistar male rats (averaging 200-250 grams each and 6-8 weeks old) were 
selected. All the animals were acclimatized in cages for 1 week prior to the surgery. 
They were randomized into 2 groups (Table 1): 
a. Group 1 (N = 30) – Lysophosphatidyl choline group with no laser therapy. 
b. Group 2 (N = 30) – Lysophosphatidyl choline followed by laser treatment (40 J by 4 




Days Group 1 (n=30)  
(Lysophosphatidyl choline) 
Group 2 (n=30)  
(Lysophosphatidyl choline + 
40J of LLLT in 4 applications) 
 
Day 0 
No. of animals 
undergoing surgical 
protocol for topical 









































































Application of 10 J 
LLLT per day on 
3rd, 4th, 5th, 6th 






























































Day 7 S      S      
Day 10  S      S     
Day 14   S      S    
Day 18    S      S   
Day 21     S      S  




Table: 1 Study design and grouping of 60 rats in two groups namely, the 
lysophosphatidyl choline group with no laser therapy and that with laser therapy. 
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Fig: 8 Arrow showing exposed sciatic nerve separated from the connective tissue using a 
blunt nerve hook ready for topical application of Lysophosphatidyl choline  
 
60 adult male Wistar rats were each anesthetized with 0.5 ml/100 gm of 7 % 
chloralhydrate intraperitoneally. The animals were enclosed in a restrainer prior to 
anesthesia. The induction time varied from 3-10 minutes. When anesthetized, the animals 
were taped onto a flat surface with their limbs extended. The surgical site was disinfected 
using a surgical swab with 70% alcohol. Local anesthesia was obtained by injecting 0.3 
ml of lignocaine HCl (2%) subcutaneously.  A horizontal incision of about 1.5-2 cm was 
made in the mid thigh region on the medial side of the hind limb with the help of a pair of 
blunt scissors. The skin was separated from the subcutaneous tissue by blunt dissection. 
Semitendinous muscle and medial gluteal muscle were identified and carefully separated 
by blunt dissection to prevent any injury (Popesko et al., 1992). After the muscles were 
separated, the sciatic nerve was exposed and separated with a blunt nerve hook. Damage 
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to the surrounding tissue was minimized by careful blunt dissection in order to reduce 
inflammation due to tissue handling. For demyelination, 10 µl of 15 mg/ml LPC 
(lysophosphatidyl choline, Sigma L4129) in physiological saline was used (Wallace et 
al., 2003). The lysolecithin solution was applied topically by a microsyringe (Exmire) 
over a length of 5-10 mm of the nerve before the juncture of the division of the sciatic 
nerve. To ensure maximal penetration by lysolecithin the legs of the animal were raised 
so that the solution would not easily drain away. The animals were left undisturbed for 15 
minutes to ensure maximal contact of the chemical agent. The chemical was then rinsed 
away with 10 ml of sterile physiological saline. Finally, the surgical wound was sutured 
using 3.0 silk sutures. 
 
2.5 Post-operative Monitoring  
Post-operatively, the animals were housed in a pathogen free environment in well-labeled 
cages. All the animals were handled in a similar manner. They were fed on rat chow and 
normal drinking water ad libitum. They were monitored for behavioral and movement 
changes within their respective cages immediately after recovery from anesthesia 
following surgery and after laser therapy. They were also monitored on a daily basis till 
the scheduled day of sacrifice.  
 
 
2.6 Laser Therapy 
 
On the 3rd post-operative day, the laser group received low-level laser therapy (LLLT) 
from a class 3B diode laser (GaAlAs, Gallium –Aluminum Arsenide, CBM master 4, CB 
medico a/s, Vaerlose, Denmark). This laser probe emits light with a wavelength of 830 
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nm, 50mW mean power output at 50 Hz. The probe diameter was 1cm with a spot size of 
0.785cm2. The total energy delivered was 40 J over 4 applications for 4 consecutive days 
(post-surgical 3rd, 4th, 5th and 6th) at an interval of 24 hours. The energy delivered per 
day was 10 J with a total energy density of 50.95 J/cm2 over 4 applications for 4 days. 
The laser probe was applied by a light touch over the skin without any undue pressure 
and hence the control group was given nothing at all ruling out the mechanical factor of 
pressure from the laser device. 
 
 









Fig. 9                                                                     Fig. 10 
 
Fig. 9 Class 3B laser system ‘CBM master 4 medical laser’ used for the experiment.  
 
Fig.10 Delivery of laser dosage along the line of suture with the left leg extended and 




2.7 Perfusion and Harvest 
Animals were sacrificed serially on 7th, 10th, 14th, 18th, 21st and 28th day using per cardiac 
perfusion through the left ventricle with 4% paraformaldehyde (PF) and 3% 
glutaraldehyde (GA) (Table 1). The sciatic nerve was harvested by opening the 
semitendinous muscle and the medial gluteal muscles through the same site as described 
for the operation.  
 
The left limb of the rat was extended while in perfusion. This helped in keeping the nerve 
structure intact by reduction of the artifacts due to fixation and lessened the scope of 
oblique sections (Geuna et al., 2001).  
 
2.8 Tissue Preparation for Electron Microscopy 
2.8.1 Tissue processing 
The samples of nerves were immersed immediately in 4% PF and 3% GA solution and 
stored overnight at 4ºC. The following day, samples were transferred to phosphate buffer 
solution of pH 7.4 for another night. Subsequently, each nerve sample was divided into 4 
parts under a dissecting microscope (Olympus) after identification of the proximal and 
distal ends of the nerve. The proximal most sample was designated as 1 and the distal 
most as number 4. Each sample was placed in a separate processing bottle and labeled 
accordingly. The 3rd part of each nerve sample was processed for electron microscopy. 
The samples were then bathed for 2 hours in 1 ml of 1% osmium tetraoxide along with a 
few crystals of potassium ferricyanide after pipetting the buffer solution under a fume 
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hood (Osmification). The bottles were capped whilst placed on a rotator. The samples 
were washed by two changes of buffer solution for 5 minutes each.  
The samples were then dehydrated with a series of alcohol changes using 25% alcohol for 
10 minutes followed by 50%, 75%, 95% and 100% alcohol for 15 minutes each 
(Dehydration). All bottles were capped following the insertion of samples in absolute 
alcohol. There after, this was followed by two changes of acetone for 15 minutes each. 
Following this, solutions of acetone and araldite in ratios of 1:1 and 1:4 were added to 
every bottle for a period of one hour each. The samples were then placed in a solution of 
acetone and araldite with ratios 1:6 overnight (Infiltration). 
Next day, pure araldite was added to each bottle and the bottles were left at room 
temperature approximately for twenty minutes in order to allow the evaporation of 
acetone. The bottles were placed in an oven at 45ºC for 1 hour. This was followed by two 
changes of pure araldite at 50ºC and 55ºC respectively for an hour each   (Appendix1). 
The samples were then embedded in a mould and placed in the oven at 60ºC for 24 hours 
for polymerization of the resin. The samples were placed along the edges of the mould to 




The samples were cut using the Leica Ultracut (Fig.11). The embedded samples were 
trimmed superficially with a razor blade to expose the nerve tissue. The nerve tissue was 
then trimmed using a glass knife. Semi-thin sections of approximately 60 µm were 
obtained and placed upon a glass slide in a drop of de-ionized water. They were dried on 
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a hotplate and stained with methylene blue. Following which, they were dried again and 



























Fig12: Semi-thin sections (60 µm) of rat’s sciatic nerve stained by methylene blue 
under light microscope to check for orientation of the samples (x 400). 
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The samples were then trimmed from the sides to remove the excess araldite for ultra thin 
sections. Ultra-thin sections ranging from 90-150 nm corresponding to golden colour 
were collected in a water boat made by using a masking tape around the glass knife. They 
were expanded with the help of a hot filament and then carried over a formvar-coated 
grid of No. 200 mesh with the help of a hair strand (Appendix2). The grids were held 
with the help of a pointed forceps and clipped to dry. Once dried, they were stored in 
gelatin capsules and labeled.  
 
 
2.8.3 Staining and viewing 
 
Following sectioning, double staining with uranyl acetate and lead citrate was done 
(Appendix 3).  The sections were viewed under Philips: 208 transmission electron 











Fig.13 Sampling method chosen for capturing the field of view under electron 
microscope at x 2200 magnification (Modified and adapted from Geuna et al, 2004) 
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Eight digital images per sample along the peripheral region of the nerve were captured 
using Gatan camera fixed to the electron microscope in accordance to the method 
modified from the systematic random sampling method developed by Geuna et al (2004) 
(Fig. 13). The method for sampling was restricted to the peripheral region only because 
the chemical LPC on topical application produces changes only in the peripheral region 
of the nerve (Girffin et al., 1990). 
 
2.9 Measurements of Axon Diameter and Fibre Diameter  
Image tool 3.0, a computer based software was used to determine the maximum diameter 
of the axons and the maximum diameter of the fibre. All the measurements were done 
along the central axis of the fibre. Calibrations were made with scale bar on the pictures 
before measurements. The procedure was blinded by randomly assigning a particular 
code to each picture by a different person. The number of axons in 8 different fields of 
view (FOV) per animal were measured and classified into 2 groups (0-3 µm and 3-6 µm). 
Axons measuring > 6 µm were excluded from the study. Following the measurements, 
the pictures were classified again according to the groups for statistical analysis. Equal 
numbers of axons per animal were then randomly selected for each axonal size and the 
mean g-ratio, myelin thicknesses were calculated. These were compared to the control 
and the treatment groups. The number of macrophages in all FOV’s was also counted for 
the 7th and the 14th day groups  
 
2.9.1 Inclusion criteria for measurements 
1) Axons that were elliptical in shape were included. 
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2) All the myelinated and demyelinated axons completely seen in the FOV were 
included. 
3) Those axons for which only a part was visible were included if, more than half the 
axon was present in the FOV.  
4) Only internodal axons were included. 
 
2.9.2 Exclusion criteria for measurement  
1) The axons for which less than half the part was present in the FOV were excluded. 
2) Those axons for which, the maximum diameter appeared to be more than three times 
the minimum diameter were excluded to avoid obliquity of the axons. 
3) Axons > 6 µm were excluded as all the animals did not present comparable numbers in 
the FOVs as large axon fibres are clustered more towards the center of the nerve than the 
peripheral region (Geuna et al., 2001).  
4) Paranodal axons and nodes of Ranvier were not included for measurements. 
5) Axons with double myelin or with intra-lamellar swelling were excluded. 
  
2.10 Statistical Analysis 
The statistical difference between lysophosphatidyl choline group and the laser treated 
group was determined by ‘Univariate analysis of variance using general linear model’ 
with software SPSS 10.0 as this test is suitable for determining interaction between the g-
ratio and myelin thickness of the laser and the non-laser groups and its effect over the 
time line. ‘Independent t-test’ was also conducted to compare the laser and the non-laser 
groups at each time point since the data showed a normal distribution and had a linear 
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relationship. Homogeneity of variance was tested using Levene test. This analysis thus 












Fig. 14 Flowchart summarizing research protocol 
 
1. Aim: To determine the myelination effects of LLLT on the rate of remyelination, g-
ratios and myelin thicknesses following lysolecithin-induced focal demyelination. 


































3. Results:  
Topical application of  
LPC on rat’s right sciatic  
nerve under general  
anesthesia 





Group receiving laser  
therapy of 40J (10J/day)  
on 3rd, 4th, 5th and 6th  
day postoperatively 
Animals perfused and  
tissue harvested on  
7th, 10th, 14th, 18th,  
21st and 28th day  
Tissue processed for  
electron microscopy 
Measurements of  
myelin thickness and  
axon diameter using  
Image tool software 








3.1 Animal Findings 
All the rats survived the surgical procedure. Following surgery, the animals were limping 
for the first 1 hour but resumed a steady gait there after. They behaved normally with 
undisturbed feeding habits. None of the animals lost weight following surgery and laser 
therapy. 
 
Univariate analysis of variance using general linear model (p< 0.05) reported an 
interaction between the laser and the non-laser groups for g-ratios of both smaller  
(p=0.000) (Graph 1) and larger axons (p=0.000) (Graph 2) (Appendix 4). Interaction was 
also found to be significant for myelin thickness for the smaller axonal group (p=0.000) 
(Graph 3) and for larger axonal group (p=0.001) (Graph 4) (Appendix 5). Results of 
‘Independent t-test’ at each time point are reported below.  
 
3.2 7th day Groups 
 
On the 7th day following LPC application, completely demyelinated axons were observed 
in the perineurial region of the nerve (Fig. 15, 16). Segmental demyelination with 
macrophages penetrating the Schwann cell cytoplasm was identified. Numerous active 
macrophages were also present (Fig. 17). Degranulated mast cells were rarely identified. 
Myelin debris was also noticed in the endoneurial space. There was an apparent scarcity 
























Fig. 15 Arrow showing one of the demyelinated axons at 7th day following topical 
application of LPC on rat’s sciatic nerve under electron microscope. Presence of an active 







































Fig. 16 Demyelinated axons in the periphery of the rat’s sciatic nerve at 7th day following 
topical application of LPC under electron microscope. Arrow pointing segmental 
demyelination and an active macrophage invading the Schwann cell cytoplasm. Another 






















Fig. 17 Segmental demyelination and an active macrophage invading the Schwann cell 
cytoplasm of the rat’s sciatic nerve at 7th day following topical application of 




However, in the laser group only a few macrophages were noticed. Completely 
demyelinated axons were rarely found. Remyelinating fibres with thin myelin sheath 
were easily identified (Fig. 18).  Granulated mast cells were rarely identified (Fig. 19). 
There seemed to be an apparent increase in the unmyelinated fibres in general however, 
they were minimal in some areas (Fig. 18). 
 
The mean g-ratio score for the axons measuring less than 3 µm, 7th day postoperatively 
was 0.8932 + 0.0482 (S.D) for the LPC group as compared with 0.6967 + 0.0133 (S.D) 
for the laser group. A significant difference between the two groups (p=0.000) was 
established (Table. 2, Graph 1). Axons measuring in between 3-6 µm on the 7th day had a 
significant difference between the g-ratio scores of 0.7545 + 0.0282 (S.D) for the LPC 



















Fig. 18: Cross-section of the peripheral region of rat’s sciatic nerve following laser 
therapy at 7th day post operatively showing only a few completely demyelinated axons. 
Arrowhead pointing the remyelinating fibres. Arrow showing the presence of an active 

























Fig. 19: Cross-section of the peripheral region of the rat’s sciatic nerve of laser group (40 
J) at 7th day postoperatively with the absence of completely demyelinated axons. Arrow 
pointing a granulated mast cell could be observed at the lower left side (x2200) 
 
A significant difference between the myelin thicknesses of smaller axons was also 
established (p=0.000). The mean myelin thickness score was 1.0236 + 0.0743 µm for the 
laser group as compared to 0.3144 + 0.2059 µm for the LPC group (Table.4, Graph 3). 
Axons measuring between 3-6 µm had a mean myelin thickness score of 2.0008 + 0.1431 
µm for the laser group and 1.4196 + 0.3140 µm for the LPC group (p=0.005) (Table.5, 
Graph 4). The total macrophage count in 8 FOV’s of the laser group was 1 as compared 
to 14 in the LPC group. 
 
3.3 10th day Groups 
On the 10th day, ballooning of myelin sheath was observed in one of the rats in the LPC 
group (Fig. 20) and another showed the presence of extensive myelin debris with 
vacuolar degeneration. In general, there was vacuolar degeneration of the myelin sheath. 
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Vacuoles were identified in the myelin sheath with swelling of Schmidt Lanterman 
incisures (Fig. 21). Whereas, the laser group on the same day, appeared to be normal with 
apparent increase in the myelin thickness (Fig. 22). The mean g-ratio scores for smaller 
axons for this day was 0.6752 + 0.0214 for the laser group and 0.7683 + 0.0420 for the 
LPC group (p=0.002) (Table 2, Graph 1) and for larger axons it was 0.6737 + 0.0323 for 
the laser group and 0.7392 + 0.0157 for the LPC group (p=0.004) (Table 3, Graph 2). The 
mean myelin thickness scores for the 10th day were 1.0873 + 0.1194 µm for the laser 
group and 0.6996 + 0.1494 for the LPC group (p=0.002) for small axons. For larger 
axonal group, it was 2.0611 + 0.3258 µm for the laser group as compared to 1.5160 + 



















Fig. 20: Arrow showing ballooning of myelin sheath at the 10th day following topical 



















Fig. 21: Vacuolar disintegration of myelin sheath of the internode on 10th day following 













Fig 22: Cross-section of the peripheral region of the rat’s sciatic nerve of laser group (40 
J) at 10th day postoperatively with the absence of completely demyelinated axons. Arrow 




3.4 14th day Groups 
Histologically, the axons and myelin sheath on the 14th day appeared to be normal (Fig. 
23, 24). However, there was a significant difference between the g-ratio and myelin 
thickness of the laser and the non-laser groups. The mean g-ratio score was 0.6749 + 
0.0159 for the laser group and 0.7150 + 0.0047 for the LPC group in the smaller axons 
(p=0.004) (Table 2, Graph 1). For the axons measuring between 3-6 µm, g-ratio was 
0.6845 + 0.0192 for the laser group as compared to 0.7130 + 0.0086 in the LPC group 
(p=0.016) (Table 3, Graph 2). The mean myelin thickness scores of small axons were 
calculated as 1.1327 + 0.1454 µm for the laser group as compared to 0.9084 + 0.0488 µm 
for the LPC group (p=0.011) (Table 4, Graph 3). However, no significant difference was 
observed for myelin thicknesses in larger axons (Table 5, Graph 4). The total number of 










Fig. 23: Electron-micrograph showing remyelinating axons on the 14th day, following 













Fig. 24: Electron-micrograph showing changes on 14th day following topical application 




3.5 18th day groups 
 
Although, there was no noticeable difference between the histology of the axons and the 
myelin sheath in the 18th day groups (Fig. 25, 26)¸ a significant difference between the 
mean g-ratio scores and myelin thickness was established for the smaller axonal group. It 
was 0.6879 + 0.0050 for the laser group and 0.7080 + 0.0045 for LPC group (p=0.000) 
(Table 2, Graph 1). The myelin thicknesses for the smaller axons were 0.9987 + 0.0337 
µm for the laser group as compared to 0.8629 + 0.0295 µm for the LPC group (p=0.000) 
(Table 4, Graph 3). However, no significant differences were found for the larger axonal 



























Fig 25: Cross-section of remyelinating axons on the 18th day, following topical 







































Fig 26: Cross-section of remyelinated axons 18th day following topical application of 
LPC with laser therapy with increased myelin thickness (x2200) 
 
3.6 21st day groups 
 
No significant differences were observed in the measurements of g-ratio and myelin 
thickness for the 21st day (Tables 2-5) (Graphs 1-4). There was no apparent difference 












Fig. 27: Remyelinating fibres with increasing axonal calibres on the 21st day following 











Fig. 28: Cross-section of sciatic nerve showing normal axonal calibers with normal 
myelin thickness on 21st day following LPC application with laser therapy (x2200) 
 
3.7 28th day groups 
On the 28th day, nerve samples were relatively normal (Fig. 29) except for 1 rat sample 
wherein hypermyelination was observed along with corresponding axonal atrophy (Fig. 
30). Membranous cytoplasmic bodies (MCBs) were seen in between the Schmidt 
Lanterman incisures. However, no such changes were identified in the laser group (Fig. 
31). Myelin sheath and axons appeared normal in the laser group. There was no 














                                 
 
 
Fig. 29: Cross-section of sciatic nerve showing normal axonal calibres with normal 












Fig. 30: Arrow pointing hypermyelination with axonal atrophy on 28th day following 












Fig. 31: Cross section of peripheral region of rat’s sciatic nerve on 28th day following 
LPC and laser therapy showing normal nerve structure (x2200) 
 
 
The results are summarized as follows: 
 
On the 7th day following topical application of LPC, demyelinated axons were prevalent 
with increased g-ratios. However, there was a significant reduction in the g-ratio in the 
laser group with more remyelinated fibers. Vacuolar degeneration was also observed in 
larger axons on the 10th day in the control group. However, no such changes were 
observed in the laser group. Smaller axons were more affected by the action of LPC as 
compared to the larger axons till the 18th day leading to an increase in the g-ratio and 
reduction in myelin thickness. Following which, no changes in the g-ratio and myelin 
thickness was observed for smaller axons. Also, no difference was observed in the g-ratio 
and myelin thickness for larger axons beyond the 14th day. Tables 2-5 and Graphs 1-4 




Table 2:  Statistical comparisons of mean g-ratios for axons measuring 0-3 µm  
 
Days LPC Laser p value 
7 0.8932 (0.0482) 0.6967 (0.0133) * 0.000 
10 0.7683 (0.0420) 0.6752 (0.0214) * 0.002 
14 0.7150 (0.0047) 0.6749 (0.0159) * 0.004 
18 0.7080 (0.0045) 0.6879 (0.0050) * 0.000 
21 0.6905 (0.0154) 0.6807 (0.0188) 0.396 





Statistical analysis using Independent t-test (p <0.05) 
* Statistically significant 
 
 


















































Graph 1: The g-ratio (axon: axon + myelin) of axons measuring 0-3 µm for the LPC and 
laser group from day 7th to 28th day postoperatively. Horizontal green lines show the 
average g-ratio (0.6-0.7) as determined by literature. 
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Table 3: Statistical comparisons of mean g-ratios for axons measuring 3-6 µm  
 
Days LPC Laser p value 
7 0.7545 (0.0282) 0.6923 (0.0069) * 0.001 
10 0.7392 (0.0157) 0.6737 (0.0323) * 0.004 
14 0.7130 (0.0086) 0.6845 (0.0192) * 0.016 
18 0.6941 (0.0171) 0.6915 (0.0068) 0.764 
21 0.6812 (0.0088) 0.6782 (0.0211) 0.782 
28 0.6853 (0.0138) 0.6955 (0.0058) 0.169 
 
 
Statistical analysis using Independent t-test (p <0.05) 






















































 Graph  2: The g-ratio (axon: axon+ myelin) of axons measuring 3-6 µm for the LPC and 
laser group from day 7th to 28th day postoperatively. Horizontal blue lines show the 






Table 4: Statistical comparisons of mean myelin thickness for axons measuring 0-3 µm  
 
Days LPC Laser p value 
7 0.3144 (0.2059) 1.0236 (0.0743) *0.000 
10 0.6996 (0.1494) 1.0873 (0.1194) *0.002 
14 0.9084 (0.0488) 1.1327 (0.1454) *0.011 
18 0.8629 (0.0295) 0.9987 (0.0337) *0.000 
21 1.0480 (0.1166) 1.0195 (0.1326) 0.727 
28 1.0952 (0.0704) 1.0181 (0.0456) 0.074 
 
Statistical analysis using Independent t-test (p <0.05) 

























































Graph 3: Myelin thickness of axons measuring 0-3µm for the LPC and laser group from 
day 7th to 28th day postoperatively. Horizontal green lines show the average range of 
myelin thickness (0.70-1.75 µm) determined from pilot study.  
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Table 5: Statistical comparisons of mean myelin thickness for axons measuring 3-6 µm  
 
Days LPC Laser p value 
7 1.4196 (0.3140) 2.0008 (0.1431) *0.005 
10 1.5160 (0.1873) 2.0611 (0.3258) *0.012 
14 1.7719 (0.1464) 2.0048 (0.3358) 0.193 
18 2.0116 (0.1943) 1.9551 (0.1367) 0.609 
21 2.1305 (0.0975) 2.0816 (0.3224) 0.754 
28 2.0703 (0.2214) 1.8976 (0.0801) 0.140 
 
Statistical analysis using Independent t-test (p <0.05) 




























































Graph 4: Myelin thickness of axons measuring 3-6 µm for the LPC and laser group from 
day 7th to 28th day postoperatively. Horizontal blue lines show the average myelin 








Discussion and Conclusion 
4.1 Introduction  
Demyelinating diseases are associated with neuropathic pain (Devor et al., 2002; Wallace 
et al., 2003). To date, there is no conclusive explanation for the mechanism of 
neuropathic pain. Therefore, the clinical management of such conditions is empirical. 
Conventionally, medication and surgical procedures are the two main treatment strategies 
employed in the management of neuropathic pain. However, treatment regimens based on 
medications have undesirable side effects and surgical treatments are associated with 
numbness and increased mortality. There is therefore a need to find a new non-invasive 
treatment strategy. In this context LLLT is a promising alternative to these conventional 
treatments. Recently, the use of LLLT has been successful in treating post-operative pain 
(Walker, 1983; Loh and Keng, 1989; Fernando et al., 1993), wound healing (Takeda, 
1988; Smith et al., 1992; Bisht et al., 1994) and nerve regeneration (Campion et al., 
1990; Miloro et al., 2002; Bagis et al., 2003; Shin et al., 2003). But, the effect of LLLT 
on remyelination has not been explored in detail. The present study was conducted to 
determine the myelination effects of LLLT by histological examination in a 
demyelinating model.   
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4.1.1 Discussion on Study Design: 
a) Sample size 
A total of 60 animals were used in this study and the left sciatic nerve was demyelinated 
following topical application of LPC. This sample size was the minimum required for a 
statistical sound comparison. 6 time periods were chosen over an experimental period of 
28 days with 5 animals per time line. Multiple time periods over 28 days were selected 
since it would be useful in determining the actual time line for delivering laser therapy 
and studying its effects.  
 
b) Control group 
The sciatic nerve from the other leg of the animal was not included as a control as it is 
established that laser therapy produces systemic effects in the body (Rochkind et al., 
1989; Tuner and Hode, 1998). The author reported that in animals with bilateral 
cutaneous wounds, which were irradiated with lasers showed enhanced recovery for both 
sides as compared to the non-irradiated animals. So in the present study 2 sets of animals 
were used, one receiving LLLT and the other with no LLLT. 
 
4.1.2 Discussion on LPC model 
Microinjection of LPC leads to complete demyelination of the nerve by its detergent 
action (Mitchell and Caren, 1982; Love et al, 1986). This animal model for 
demyelination was first developed by Hall and Gregson (1971). Similar animal model 
with topical application of LPC was developed by Griffin et al (1990) and Wallace et al 
(2003), which simulated a neuropathic pain model.  In the present work, the animal 
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model was adapted from the study by Wallace et al (2003) as it was felt that injection of 
LPC might inflict axonal injuries leading to axonal atrophy and consequential changes in 
the myelin sheath.  In the present study, 6-8 weeks old Wistar male rats weighing 200-
250 gms were chosen as this age-group has been used for similar studies (Takeda, 1988; 
Griffin et al., 1990). This also ruled out the bias related to strain, gender and age of all the 
animals (Geuna et al., 2001). Sciatic nerve from smaller animals like mice would be 
difficult to handle. Larger animals like rabbits would add on to the procuring costs. 
 
The pilot phase of this study was designed to rule out any possible effects of saline on the 
sciatic nerve and also to define the laser parameters chosen for the main experiment. In 
the pilot phase, there was one saline group, one LPC group and 2 laser groups with 40 J 
and 80 J energy delivered over a spot size of 0.785 cm2. In the pilot phase, 1 animal for 
each group was included except the 4th day LPC group in which 5 animals were included. 
In the 4th day LPC group, it was observed that most of the axons were demyelinated (Fig. 
34, 35, Appendix 4). Unmyelinated axons were separated by Schwann cell cytoplasm. 
‘Bands of Bungner’ were also observed on the 4th day following LPC application (Fig. 
34, Appendix 4). Bands of Bungner are normally seen after axonal injury or following 
any inflammation. They are formed because of proliferation and multiplication of 
Schwann cell cytoplasm following destruction of myelin sheath (Albert, 1979). Myelin 
debris could easily be identified along with active macrophages, which strip off the 
myelin sheath away from the axons. 
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The saline group did not show any changes as observed in the LPC group. The saline 
group acted as a baseline to estimate the normal g-ratio and myelin thickness for the 
different axonal sizes with one animal per time line (Fig. 33, Appendix 4). The values of 
g-ratio and myelin thickness for various time lines were comparable. The mean g-ratio 
measured ranged from 0.59 to 0.72 in the smaller axonal group and 0.62 to 0.68 in the 
larger axonal group which are comparable with the normal g-ratio of 0.60-0.70 as 
determined by literature (Smith and Koles, 1970; Hildebrand et al., 1994). The mean 
myelin thicknesses determined for the smaller axonal group and the larger axonal groups 
in the baseline saline group were 0.70-1.75 µm and 1.81-2.73 µm respectively.   
 
In the laser groups, it was observed that the group receiving 80 J of laser therapy showed 
axonal atrophy with corresponding hypermyelination on the 21st day following therapy 
(Fig. 36, Appendix 4). It was therefore decided that energy of 80 J over a spot size of 
0.785 cm2 produced detrimental effects and hence this group was excluded from the main 
experiment. 
 
The small size for the pilot study was a limiting factor in this study. A larger sample size 
would allow us for better statistically sound conclusions made in the pilot study for the 
80 J laser group and the baseline saline groups. An additional control group whereby no 
surgical procedures were conducted would also be meaningful for better understanding of 




4.1.3 Discussion on Methodology: 
a) Selection of nerve area 
In this study, LPC was topically applied over a length of 5-10 mm before the point of 
trifurcation of the sciatic nerve. This area of the nerve was harvested and divided further 
into 4 equal parts after determining the proximal and distal end. Every 3rd part of the 
nerve was then processed and embedded in araldite resin for electron microscopy. This 
helped to rule out any possible bias for the variation in sizes of the fibres along the length 
of the nerve (Geuna et al., 2001).  
 
b) Processing 
Tissue shrinkage due to improper fixation is an inevitable problem as faced by many 
researchers. Perfusion fixation prevented any time lapse between the harvest and fixation. 
This was also reduced by immediately transferring the nerve samples to the fixative 
following their harvest (Geuna et al., 2001).   
 
c) Sectioning 
Longitudinal sections were not taken for the fact that topical application affects the 
periphery only and such sections would not give a complete picture of the changes 
(Griffin et al., 1990; Wallace et al., 2003). 
 
d) Sampling 
As the chemical LPC on topical application, produces demyelination of the peripheral 
region of the nerve sparing the inner axial region, samples along the perineurial region 
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Morphologically, myelinated nerve fibres can be assessed by various parameters like 
diameter of the fibre (maximum, minimum and mean), the perimeter and the cross- 
sectional area of the fibre and the axons. These may be used for calculating the myelin 
thickness and hence determine myelination, demyelination and remyelination of a nerve 
fibre. The measurement of g-ratio is well documented as an empirical method to assess 
the myelin thickness (Gautron et al., 1990; Wallace et al., 2003; Constant et al., 2004; 
Michailov et al., 2004).  
 
f) Laser parameters 
In the present study, GaAlAs diode laser with λ of 830 nm was used as it has been proven 
that λ in the infra-red range (780-830 nm) would be less absorbed by the superficial 
tissues sparing them from the photothermal effects of lasers (Prasad, 2003). LLLT does 
not produce any photothermal effects, as it does not lead to any significant increase in the 
temperature of the tissues but produces photochemical effects (Gupta, 1997). Energy 
density of 50.95 J/cm2 was used in the current study as it was comparable with similar 
studies on nerve regeneration (Khullar et al., 1995; Gigo-Benato et al., 2004). Similar 
dosage was also used for wound healing (Mendez et al., 2004). In the past, energies less 
than 1 J/cm2 were used too. But, this energy was far too low to produce any biological 
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responses, which could be the probable reason for their negative results (Tuner and Hode, 
1998). 
 
Laser application                                                                                                               
In the present study, LLLT was applied perpendicular and in contact with the tissue 
surfaces to avoid any scattering or loss of energy (Prasad, 2003). This increased the 
absorption of laser and hence no energy was wasted. 
 
4.2 Discussion on Results 
 
4.2.1 Pilot study  
 
It is well established that LPC causes an immediate degenerative effect on myelin sheath 
(Hall and Gregson, 1971). The authors found that myelin splitting began as early as 30 
minutes following LPC injection (20 µl of 10 mg/ml LPC). In another study by Griffin et 
al (1990), 100-300 µl of 0.02 mg/ml LPC was topically applied over the rat’s sciatic 
nerve. However in the present study, 10 µl of 15 mg/ml LPC in physiological saline was 
used for topical application, which was modified and adapted from Wallace et al (2003). 
The concentration of LPC used in this study was acceptable and comparable with the 
previous studies. It was found that most of the axons present perineurally appeared 
demyelinated on the 4th day following LPC application (Fig 34, 35, Appendix 4). These 
findings reviewed that LPC leads to demyelination of the previously myelinated axons.  
At the end of the 4th day, the cross-section of the LPC affected nerve could be divided 
into three zones namely, the outermost demyelinated zone, an intermediate zone and the 
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innermost unaffected zone (Fig. 32, Appendix 4). This was clearly visible under light 
microscopy and similar observations were described by Griffin et al (1990).  
 
It was found that all traces of myelin sheath were replaced by debris following LPC 
application on the 4th day. These findings determined in the pilot phase of the study 
reviewed that demyelination of the axons began on the 4th day following LPC 
application. It was hence decided to deliver LLLT on the 3rd day following LPC 
application to allow a delivery of 40 J of energy in 4 equal applications of 10 J per day 
over a period of 4 days. Lastly, in the saline group, there was no effect of saline upon the 
nerve tissues, and therefore, it did not interfere with the effect of LPC on the nerve (Fig. 
33, Appendix 4). 
 
4.2.2 7th day results 
In the present study, on the 7th day laser group, remyelination was well established with a 
significant reduction in the g-ratio for both the smaller (p=0.000) and the larger axonal 
groups (p=0.001) (Tables 2, 3). Corresponding increase in the myelin thickness for both 
axonal sizes was also measured (Tables 4,5). There was an apparent reduction in the 
number of demyelinated perineurial axons in the laser group (Fig. 18, 19) as compared to 
the non-laser group (Fig.15, 16). Segmental demyelination with numerous active 
macrophages was more prominent in the non-laser group (Fig. 17).  
 
In the present work, macrophages were rarely observed in the 7th day laser group. There 
was a total of 14 macrophages observed in the FOVs of the non laser group as compared 
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to 1 in the laser group, 7th day postoperatively. It has also been reported that LLLT 
accelerates phagocytosis (Tadakuma, 1993; Basford, 1995). The significant differences 
observed in the g-ratio and myelin thickness on the 7th day could be due to an increase in 
the number of macrophages then clearing the myelin debris and resulting in faster 
remyelination. Also, they reported that an inhibition of macrophage function and number 
delayed remyelination (Kotter et al., 2001; Kotter et al., 2005). In a study by Pavelko et 
al (1998), enhanced remyelination following lysolecithin induced CNS demyelination 
was observed following the manipulation of the inflammatory response. Macrophages 
may produce or enhance the release of soluble growth factors, which may further enhance 
the proliferation of fibroblasts promoting healing (Young et al., 1989; Bolton et al., 1991; 
Rajaratnam et al., 1994). Changes in the mRNA expression of insulin-like growth factor-
1 and transforming growth factor β1 due to macrophage depletion have also been 
reported to affect the behavior of oligodendrocyte progenitor cells and the remyelination 
process (Kotter et al., 2005). 
  
On the 7th day laser group, there seemed to be an apparent increase in the granulated mast 
cells (Fig.19). However, degranulated mast cells were also identified on the 7th day non-
laser group, which indicated that there was release of neurotoxic and inflammatory 
products. An increase in the number of mast cells following laser irradiation has also 
been reported (El Sayed and Dyson, 1994). Mouse and human mast cells, which contain 
and secrete NGF (Theoharides and Cochrane, 2004) act on the PNS and the CNS neurons 
and enhance their survival and regeneration following axotomy (Lundborg, 1987; Yuen 
and Mobley, 1996).  
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Schwann cells are known to play an important role in the myelination process in the PNS 
(Constant et al., 2004). LLLT has even been reported to enhance proliferation of 
Schwann cells (Van-Breugel and Bar, 1993). These cells might also convert to 
phagocytes in pathology or following chemical injury (Pannese, 1994). It was also 
believed that the degeneration products of myelin sheath had some mitogenic effect on 
the Schwann cells resulting in their proliferation following LPC application (Griffin et 
al., 1990). 
 
There seemed to be an apparent reduction in the number of unmyelinated nerve fibres in 
the non-laser group as compared to the laser group (Fig. 16, 19) however, they seemed to 
have reduced in number in a few areas (Fig. 18).  These observations were in congruence 
with the previous studies by Mitchell and Caren (1982) who mentioned the reduction of 
unmyelinated fibres following LPC application.  
 
4.2.3 10th day results 
 Remyelination in the laser group continued on the 10th day with a significant reduction in 
the g-ratio for axons measuring less than 3 µm (p=0.002) and those measuring between 3-
6 µm (p=0.004) (Table 2, 3).  Corresponding myelin thickness for both smaller (p=0.002) 
and larger axons (p=0.012) was also significantly increased (Table 4, 5). However, 
demyelination was conspicuously observed (ballooning and vacuolar degeneration of the 
myelin sheath) in the non-laser group. Vacuolar degeneration of the myelin sheath has 
also been described by Griffin et al (1990) on the 4th day following topical LPC 
application and immediately following its injection by Hall and Gregson (1971). Presence 
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of myelin debris along with swelling of Schmidt Lanterman incisures was also evident in 
the present study (Fig. 20, 21).  
 
4.2.4 14th day results 
Evidence of remyelination on the 14th day laser group was also evident from a significant 
reduction in g-ratio for the smaller (p=0.004) as well as the larger axons (p=0.016) 
(Tables 2, 3). A correspondingly thicker myelin was also observed for smaller axons in 
the laser group (p=0.011) as compared to the non-laser group (Table 4). However, no 
difference was observed for axons measuring 3-6 µm (Table 5). This was also highlighted 
by Mitchell and Caren (1982) following topical application of LPC.  This selective action 
of LPC on the smaller axonal group could be due to the pattern of axonal distribution in 
the nerve. The distribution of the axonal fibres in the nerve is such that most of the larger 
axons are arranged towards the center of the nerve and the smaller axons are clustered 
along the periphery (Geuna et al., 2000). Thus, topical application of LPC is expected to 
affect the peripheral smaller axonal fibres more than the axial larger axonal fibres. Also, 
laser therapy would affect the peripheral smaller axons more than compared to the axial 
larger axons. Moreover, it has also been proposed that myelination starts earlier in larger 
axons as compared to smaller axons (Hildebrand et al., 1994), which could further 
explain the observations made in the current study.  
 
In the current study, the demyelinated fibres on the 14th day were apparently lesser than 
reported by Wallace et al (2003). The authors reported the presence of 40% demyelinated 
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axons on the 13th day following LPC application on the mice’s sciatic nerve. No further 
investigations were made beyond the 13th day following topical application LPC.   
 
The present study was conducted over a period of 28 days instead of 13 days (Wallace et 
al., 2003). This was designed to determine the long-term effect of LLLT on demyelinated 
nerves. Moreover in the pilot study, axonal atrophy with corresponding hypermyelination 
was observed on the 21st day (in the 80 J laser group) and also in 1 of the animals 
sacrificed on the 28th day following LPC application (Fig. 36, Appendix 4). There was an 
apparent increase in the number of granulated mast cells in the laser group also (Fig. 24). 
Role of mast cells may be explained as described previously. 
 
4.2.5 18th day results 
On the 18th day, remyelination continued for the smaller axons as evidenced by 
significant reduction of the g-ratio for the smaller axonal group (p=0.000) and a 
corresponding increase in the myelin thickness (p=0.000) (Tables 2, 4). However, there 
was an insignificant difference for the larger axons implying that larger axons were less 
affected by LPC (Tables 3, 5). The possible reason for significant difference between the 
g-ratio and myelin thickness for the smaller axons may be explained as previously 
mentioned. 
 
4.2.6 21st and 28th day results 
On the 21st and the 28th day, there was no significant difference between the g-ratio and 
the myelin thickness of both the laser and the non-laser groups for either axonal sizes 
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(Tables 2-5) implying that physiological as well as LLLT induced remyelination process 
had been completed by the 21st day already. 
 
In the present study, it was found that LLLT helped in the remyelination process in the 
early stages of demyelination of nerves. This finding was compatible with the effects of 
LLLT on early stages of nerve recovery following standard crush injuries of the rat’s 
sciatic nerve (Shin et al., 2003). The possible explanation for the myelination effects of 
LLLT might be because of an accelerated growth of macrophages after demyelination 
immediately following its application. This might have led to a faster clearing up of 
myelin debris and hence accelerated remyelination (Rajaratnam, 1994). Schwann cell 
proliferation following LLLT might also be one of the possible factors leading to 
remyelination (Van- Breugel and Bar, 1993). This could be because of LLLT mediated 
increase in the production of ATPs, DNAs and cell proliferation (Karu, 1989). LLLT 
might encourage axonal growth by the stimulation of neurotrophic factors (NGF) 
released from mast cells and thereby indirectly stimulating remyelination (Theoharides 
and Cochrane, 2004). The other possible explanation for remyelination in the present 
study may be due to the suppression of neurotoxic effects of nitric oxide activity and 
upregulation of the expression of transforming growth factor 1 (TGF-1) which is a 
neuroprotective agent (Leung et al., 2002). LLLT might have even upregulated the 
myelin genes and regulated myelination in a demyelinated nerve. It might even affect 
Neuregulin 1 (Ngr 1) providing a signal for increasing the myelin thickness (Michailov et 
al., 2004). The explanation of the underlying mechanism for remyelination was beyond 
the scope of this present study, but certainly deserves a future investigation. 
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4.3 Conclusions 
Based on the results of the present study, it was inferred that LLLT application might 
enhance the rate of remyelination process leading to faster and thicker myelin sheath as 
compared to the controls. There was a statistically significant difference between the g-
ratio and the myelin thickness for the smaller axons measuring less than 3 µm for the 
laser and the non-laser groups till 18th day and no difference was observed beyond this 
point. A significant difference between the two groups for g-ratio and myelin thickness 
till the 10th day for larger axonal group was also recorded. However, the g-ratio on the 
14th day for larger axonal group was significantly lower for the laser group compared to 
the LPC group with no difference between the myelin thicknesses for this day. Following 
the 14th day, no significant difference between the g-ratio and myelin thickness was 
observed. It was therefore, concluded that either LPC affected the smaller axons more 
than the larger axons or the myelination process was faster in the larger axons. This could 
also be due to the pattern of distribution of the axons in a nerve. 
 
No significant difference was found for larger axonal group on the 18th day and for both 
the axonal groups on the 21st and 28th days. It was thus concluded that beyond 18th day, 
normal physiological healing had taken its course. It was also inferred that application of 
LLLT in the initial stages of demyelination played an important role in the myelination 





4.4 Future Directions 
The present study showed that low-level laser therapy might promote the myelination 
process following its application in the initial stages of demyelination in a focal 
demyelination animal model. Studies whereby, application of LLLT is delayed following 
demyelination may also contribute significantly to its remyelination effects during the 
later stages of demyelination. Further studies are warranted to confirm if this effect is 
also applicable to completely demyelinated nerves. Knowledge of optical properties of 
the neural tissues would also be meaningful in determining the optimal laser parameters, 
which could be absorbed by the nerve tissue to produce beneficial effects for myelin 
formation.  
 
Multiple wavelengths may also be investigated as it may enhance photobiostimulation 
leading to faster remyelination. Immunolocalization of the sodium and potassium 
channels along the nerve fibre are also advised to confirm the photobiological effects of 
LLLT on remyelination. Studies to determine the effect of LLLT on non-neuronal 
elements such as Schwann cells, perineurial cells, macrophages and mast cells would 
possibly give a better explanation of the results found in this study. Following which, 
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Appendix 1: Preparation of araldite mixture 
 
 
Araldite mixture is prepared by mixing the following components 
 
 
Epoxy monomer  Araldite M          
 
90 gm 
Hardener DDSA 80 gm 
 
Accelerator DMP-30 2.5 gm 
 
 
The resin and the accelerator were weighed and mixed well. Following which the 
hardener was added. The mixture was stirred gently to prevent the entrapment of air 

















Appendix 2: Formvar coating for grids 
 
For formvar coating, 3” x 1” microscope slide were cleaned with a saturated soap 
solution and dried with a towel to remove all the dust particles. 
 
The slide was then dipped in a solution of 0.3 % Formvar in chloroform for a few 
seconds.  
The slide was then quickly transferred to a bottle with a chloroform soaked filter paper 
placed in it along with glass beads with the lip closed. The slide was left there for 30 
seconds. 
 
After the slide is withdrawn from the bottle, scores were made on all the four sides with 
the help of a pointed forceps. 
 
The slide is then lowered in a dish containing deionized water to detach the Formvar 
coating and made to float in water. 
 
Following which cleaned copper grids were placed one by one with the dull surface or 
the grids facing downwards (Copper grids were cleaned with 2 changes of acetone using 
a sonicator).  
 
The film with the grids was then picked up with the help of a wax paper. They were then 
spead over a hotplate with the help of clips for it to dry. They were then stored in a 
petridish.  
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Appendix 3: Double staining with Uranyl acetate and Lead citrate 
 
For aqueous solution of uranyl acetate is dissolved in deionised water to make saturated 
solution. It should be left untouched overnight before usage for sedimentation of the 
excess. 
 
For 50ml lead citrate solution, 1.33gm of lead nitrate, 1.76 gm of sodium citrate and 30 
ml of distilled water is taken in a volumetric flask. The mixture should be shook for the 
first minute and frequently for the next 30 minutes. This results in a milky suspension. 
Following this, 8ml of 1N of sodium hydroxide  (NaOH) is added. This turns it into a 
clear solution. Additional de-ionised water is added to top up the volume to 50 ml. The 
solution can be stored at 4° C for several months. 
 
For staining grids, a clean pipette is used to withdraw uranyl acetate solution from 
midway avoiding the precipitated salt at the bottom of the bottle. The initial drops are 
ejected to avoid precipitates due to evaporation. Drops of uranyl acetate are ejected on a 
wax plate in a petridish. 
 
A grid to be stained is held by a tweezers and placed facing the section facing the drop 
covering the petridish immediately. The procedure is repeated for all the grids. The grid 
is left for 10 minutes. Following which, the grids are washed thoroughly with deionised 
water. The grids are made free from water and drip dry with a filter paper.  
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For lead citrate staining, lead citrate is removed with the help of a clean pipette and 
placed on a wax plate in a petridish containing lithium hydroxide (LiOH). This is because 
lead citrate reacts with CO2. The grids are placed in the similar way as described 
previously with the lid covered all the times. The grids are placed for 8 minutes washed 





































Fig 32:  Cross section of the rat’s sciatic ne
methylene blue staining of the semi-thin section
pointing the outermost demyelinated zone by the




















Fig 33:  Cross section of the rat’s sciatic ne
methylene blue staining of the semi-thin section
day following topical application of saline showin
 
 *rve under light microscope following 
 of rat’s sciatic nerve (60 µm). Arrow 
 LPC (4th day), asterisk an intermediate 
ected zone x 200 
rve under light microscope following 
 of rat’s sciatic nerve (60 µm) on the 4th 










Fig 34: 4th day following topical application of LPC on rat’s sciatic nerve. ‘Bands of 
Bungner’ (Cluster of schwann cell processes in a single basement membrane) are pointed 
















Fig 35: 4th day following topical application of LPC on rat’s sciatic nerve. Arrow 
pointing an active macrophage leading to segmental demyelination. Arrowhead pointing 



















Fig 36: 21st day following topical application of LPC and 80J of LLLT on rat’s sciatic 

































Tests of Between-Subjects Effects
Dependent Variable: GRATIO1
.212a 11 1.928E-02 39.600 .000
30.548 1 30.548 62751.829 .000
5.023E-02 1 5.023E-02 103.180 .000
8.821E-02 5 1.764E-02 36.241 .000














of Squares df Mean Square F Sig.























Tests of Between-Subjects Effects
Dependent Variable: DIFF1
2.866a 11 .261 21.082 .000
52.344 1 52.344 4236.133 .000
.761 1 .761 61.590 .000
1.043 5 .209 16.889 .000














of Squares df Mean Square F Sig.




























Tests of Between-Subjects Effects
Dependent Variable: GRATIO2
3.409E-02a 11 3.099E-03 10.137 .000
29.283 1 29.283 95796.599 .000
9.579E-03 1 9.579E-03 31.336 .000
1.136E-02 5 2.272E-03 7.434 .000














of Squares df Mean Square F Sig.















  Table 8: Univariate analysis of variance for g-ratios of larger axons (gratio2) 
 
 
Tests of Between-Subjects Effects
Dependent Variable: DIFF2
2.856a 11 .260 5.026 .000
218.902 1 218.902 4237.633 .000
.487 1 .487 9.427 .004
1.044 5 .209 4.043 .004














of Squares df Mean Square F Sig.
R Squared = .535 (Adjusted R Squared = .429)a. 
 
 
Table 9: Univariate analysis of variance for myelin thickness (Diff 2) of larger axons 
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